Definitive Contract HHSD200201688482C
Award Date
12/18/15
Potential Completion Date
2/28/17
Potential Value
$84M
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Swiftwater, PA 18370, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Sanofi Pasteur Inc., a pharmaceutical company, by the Centers for Disease Control and Prevention (CDC) to provide adult influenza vaccines. The contract is a definitive contract with a firm fixed price of $81,449,899.60 and an ultimate completion date of February 28, 2018. There is no set-aside designation for this award. Sanofi Pasteur Inc. is the prime contractor and has provided a range of vaccine products and services to various federal agencies, including...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a definitive, firm fixed price contract to Sanofi Pasteur Inc. for the delivery of adult influenza vaccines. The contract has a potential value of $81,449,899.60 and a completion date of February 28, 2019. The place of performance is Atlanta, Georgia. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, medical supplies, and related services to U.S....
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit organization that manufactures vaccines and pharmaceutical products. The contract, valued at $330,149,915.00, is for the delivery of 2016 seasonal and pre-pandemic influenza vaccines to support the CDC's public health preparedness and disease prevention efforts. The contract was awarded on a firm fixed-price basis without any set-aside designation, and...
This is a $87,130.68 firm fixed price purchase order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc. for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 29, 2021 and does not have a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, and medical supplies to federal agencies. The company holds several indefinite delivery vehicles (IDVs) with agencies...
This is a $35,673,100.00 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the provision of vaccines, pharmaceuticals, medical supplies, and related services, with performance to occur at Sanofi Pasteur's Swiftwater, Pennsylvania facility or other designated locations. The contract is not associated with a set-aside designation. Sanofi Pasteur Inc. holds several...
This is a firm fixed price delivery order awarded by the Indian Health Service, a civilian agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the annual purchase of influenza vaccines. The $72,385.25 contract ensures the National Supply Service Center (NSSC) maintains sufficient quantities of the influenza vaccine for ages six months and older per CDC recommendations. The vaccine helps prevent illnesses, medical visits, hospitalizations, and deaths. This...
This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $12,907.62, is for the supply of influenza virus vaccines. The contract has an ultimate completion date of March 31, 2025. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers for Disease Control and...
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned for-profit organization, to provide a variety of adult vaccines to the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a definitive contract with a firm fixed price, valued at $36,284,020.90, and does not have a set-aside designation. The period of performance is from July 1, 2017, to June 30, 2018, with the place of performance being Sanofi Pasteur's facility in...
This federal contract award to Sanofi Pasteur Inc. is for the delivery of influenza virus vaccines. The contract, valued at $1,032.12, was awarded by the Medical Supply Chain unit of the Defense Department's Defense Logistics Agency. It is a firm fixed price purchase order without any set-aside designation. Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, is the prime contractor. The contract utilizes Sanofi Pasteur's production and distribution capabilities to provide vaccines in...